Literature DB >> 12435708

Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.

Elisenda Miró1, Ferran Navarro, Beatriz Mirelis, Montserrat Sabaté, Alba Rivera, Pere Coll, Guillem Prats.   

Abstract

About 7% of 7,252 nonduplicated clinical Escherichia coli strains from a Spanish hospital showed reduced susceptibility to amoxicillin-clavulanate. Of these, 0.37% produced the IRTs TEM-30, TEM-31, TEM-33, TEM-34, TEM-37, TEM-40, TEM-51, and TEM-54; 5.3% were probable class C beta-lactamase overproducers; 0.8% were probable TEM-1 hyperproducers; 0.18% produced OXA-30; 0.15% overexpressed SHV-1; and 0.03% produced a PSE-1 enzyme.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12435708      PMCID： PMC132771          DOI： 10.1128/AAC.46.12.3991-3994.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors:  E B Chaïbi; D Sirot; G Paul; R Labia
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

2.  Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993.

Authors:  F Espinasse; R Gheorghiu; A Poiata; R Labia; M H Nicolas-Chanoine
Journal:  J Antimicrob Chemother       Date:  1997-01       Impact factor: 5.790

3.  Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.

Authors:  E Miró; M del Cuerpo; F Navarro; M Sabaté; B Mirelis; G Prats
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

4.  Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.

Authors:  M M Caniça; C Y Lu; R Krishnamoorthy; G C Paul
Journal:  J Mol Evol       Date:  1997-01       Impact factor: 2.395

5.  Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

Authors:  E E Prinarakis; V Miriagou; E Tzelepi; M Gazouli; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

6.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Authors:  P Stapleton; P J Wu; A King; K Shannon; G French; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

7.  Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Authors:  D Sirot; R Labia; P Pouedras; C Chanal-Claris; C Cerceau; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  [Incidence of extended spectrum beta lactamase in Escherichia coli in a university hospital from 1994-1996].

Authors:  M Sabaté; C Vergés; E Miró; B Mirelis; F Navarro; E del Río; G Prats
Journal:  Enferm Infecc Microbiol Clin       Date:  1999-10       Impact factor: 1.731

9.  Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli.

Authors:  C Henquell; C Chanal; D Sirot; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.

Authors:  A Oliver; M Pérez-Vázquez; M Martínez-Ferrer; F Baquero; L De Rafael; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191
View more
  9 in total

1.  Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain.

Authors:  Oihane Martín; Aránzazu Valverde; María I Morosini; Mario Rodríguez-Domínguez; Mercedes Rodríguez-Baños; Teresa M Coque; Rafael Cantón; Rosa del Campo
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

2.  Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.

Authors:  Bashar W Shaheen; Rajesh Nayak; Steven L Foley; Ohgew Kweon; Joanna Deck; Miseon Park; Fatemeh Rafii; Dawn M Boothe
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

3.  CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel.

Authors:  Inna Chmelnitsky; Yehuda Carmeli; Azita Leavitt; Mitchell J Schwaber; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.

Authors:  Adriana Ortega; Jesús Oteo; Maitane Aranzamendi-Zaldumbide; Rosa M Bartolomé; Germán Bou; Emilia Cercenado; M Carmen Conejo; Juan José González-López; Mercedes Marín; Luis Martínez-Martínez; María Merino; Ferran Navarro; Antonio Oliver; Alvaro Pascual; Alba Rivera; Jesús Rodríguez-Baño; Irene Weber; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

Review 5.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

6.  Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period.

Authors:  John Kiiru; Samuel Kariuki; Bruno M Goddeeris; Patrick Butaye
Journal:  BMC Microbiol       Date:  2012-07-28       Impact factor: 3.605

7.  Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain.

Authors:  Jesús Oteo; José Campos; Edurne Lázaro; Oscar Cuevas; Silvia García-Cobos; María Pérez-Vázquez; F J de Abajo
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

8.  Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.

Authors:  Benjamin K Chan; Mark Sistrom; John E Wertz; Kaitlyn E Kortright; Deepak Narayan; Paul E Turner
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

9.  High prevalence and diversity of extended-spectrum β-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia.

Authors:  Laila Darwich; Anna Vidal; Chiara Seminati; Andreu Albamonte; Alba Casado; Ferrán López; Rafael A Molina-López; Lourdes Migura-Garcia
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.